Development of novel therapy targeting cancer stem cells by ROS regulation
Project/Area Number |
24390448
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Partial Multi-year Fund |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Hokkaido University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
OHGA Noritaka 北海道大学, 大学院歯学研究科, 助教 (40548202)
TEI Kanchu 北海道大学, 大学院歯学研究科, 教授 (80180066)
OHIRO Yoichi 北海道大学, 大学院歯学研究科, 講師 (40301915)
進藤 正信 北海道大学, 歯学研究科(研究院), 教授 (20162802)
樋田 京子 北海道大学, 大学院・歯学研究科, 特任准教授 (40399952)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥18,330,000 (Direct Cost: ¥14,100,000、Indirect Cost: ¥4,230,000)
Fiscal Year 2014: ¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2013: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2012: ¥7,800,000 (Direct Cost: ¥6,000,000、Indirect Cost: ¥1,800,000)
|
Keywords | 血管新生阻害 / 腫瘍 / 微小環境 / 活性酸素 / 腫瘍血管内皮細胞 / 転移 / VEGF / 腫瘍血管内皮 / がん幹細胞 / 腫瘍血管 / 腫瘍微小環境 |
Outline of Final Research Achievements |
Reactive Oxygen Species (ROS) are known as the origin of oxidative stress. ROS are produced in response to hypoxia and nutrient deprivation. It is reported that tumor microenvironment is often exposed to hypoxic condition and nutrient deprivation because of the insufficient blood flow. ROS are accumulated in various cells in tumor microenvironment, and they promote cancer malignancy. In this study, we analyzed the effect on cancer stem cells and tumor blood endothelial cell that is reported to play a role as stem cell niche. ROS accumulation caused in alteration of gene expression profile both in cancer cells and tumor endothelial cells. One secreted protein from tumor endothelial cells was upregulated by ROS and attracted cancer cells. We analyzed the effect of ROS inhibition on cancer stem and tumor angiogenesis.
|
Report
(4 results)
Research Products
(16 results)
-
[Journal Article] Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel2015
Author(s)
1.Akiyama K., Maishi N., Ohga N., Hida Y., Ohba Y., Alam Mohammad Towfik, Kawamoto T., Ohmura H., Yamada K., Torii C., Shindoh M. and *Hida K.
-
Journal Title
Am J Pathol
Volume: 185(2)
Issue: 2
Pages: 572-580
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Identification of Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity and a Highly Angiogenic Phenotype2014
Author(s)
2.Ohmura-Kakutani H., Akiyama K., Maishi N., Ohga N., Hida Y., Kawamoto T., Iida J., Shindoh M., Tsuchiya K., Shinohara N., *Hida K
-
Journal Title
PLoS ONE
Volume: 9(12)
Issue: 12
Pages: e113910-e113910
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Identification of Novel Targets for Antiangiogenic Therapy by Comparing the Gene Expressions of Tumor and Normal Endothelial Cells2014
Author(s)
Otsubo T., et al., Hida Y., Ohga N., Sato H., Kai T., Matsuki Y., Takasu H., Akiyama K., Maishi N., Kawamoto T., Shinohara N., Nonomura K., Hida K.
-
Journal Title
Cancer Sci.
Volume: (印刷中)
Issue: 5
Pages: 560-567
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Lysyl oxidase secreted by tumour endothelial cells Promotes angiogenesis and metastasiso2013
Author(s)
Osawa T., et al., Ohga N., Akiyama K., Hida Y., Kitayama K., Kawamoto T, , Yamamoto K., Maishi N., Kondoh M., Onodera Y., Fujie M., Nonomura K., Shindoh M., Hida K.
-
Journal Title
Br. J. Cancer
Volume: 109(8)
Issue: 8
Pages: 2237-2247
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma2013
Author(s)
Akiyama K., Ohga N., Maishi N., Hida Y., Kitayama K., Kawamoto T., Osawa T., Suzuki Y., Shinohara N., Nonomura K., Shindoh M., Hida K.
-
Journal Title
Pathol. Int.
Volume: 63(1)
Issue: 1
Pages: 37-44
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-